Marinomed Biotech AG (VIE:MARI)

Austria · Delayed Price · Currency is EUR

14.20

+0.10 (0.71%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Virology	11.20M	9.69M	8.08M
Virology Growth	15.59%	19.83%	31.90%
Immunology	-	1.91M	39.00K
Immunology Growth	-	4805.13%	160.00%
Other	77.70K	26.80K	500.00
Other Growth	189.93%	5260.00%	-
Total	11.28M	11.63M	8.12M
Total Growth	-3.03%	43.12%	32.22%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Austria	335.00K	536.00K	987.50K	603.40K	441.20K
Austria Growth	-37.50%	-45.72%	63.66%	36.76%	333.40%
Other European Countries	3.38M	4.46M	6.86M	5.87M	5.32M
Other European Countries Growth	-24.34%	-34.92%	16.79%	10.42%	33.25%
Non-European Countries	1.04M	4.06M	3.43M	5.15M	2.37M
Non-European Countries Growth	-74.48%	18.28%	-33.40%	117.75%	15.28%
Total	4.75M	9.06M	11.28M	11.63M	8.12M
Total Growth	-47.59%	-19.67%	-3.03%	43.12%	32.22%

Source: S&P Global Market Intelligence.